News, info and tips for living with multiple sclerosis

Three tools to help you choose the right MS treatment

Choosing the best disease-modifying therapy (DMT) to treat your MS can be a tough decision.  When I was diagnosed with MS way back in 1980, it was easy. There were no DMTs to choose from. The first three — Avonex (interferon beta-1a), Betaseron (interferon beta-1b), and Copaxone (glatiramer acetate injection) — weren’t approved in the U.S. until the early-to-mid 1990s. Today, there are more than 20 MS treatments on the…Continue Reading

Who’s in Charge, You or Your Neurologist?

To be in charge be a boss

Is treating multiple sclerosis only about being treated with a medication? At least one neurologist thinks so, and probably more. The other day, posting in an MS Facebook group, a woman named Debbie wrote about her first visit with a new neurologist: “He asked if I was on a DMD [disease-modifying therapy] and I told him not anymore. I’ve had bad experiences. He told me that he wouldn’t treat me…Continue Reading

This Tool Can Help You Choose an MS Treatment

MS treatment choice

It’s not easy choosing a MS treatment. There are shots and pills and intravenous infusions. The National Multiple Sclerosis Society lists more than 20 disease-modifying therapies (DMTs) on its website. Some, such as Lemtrada (alemtuzumab), Ocrevus (ocrelizumab), and Tysabri (natalizumab), have proven to be effective at slowing the progression of MS. Others, less so. All DMTs have potential side effects, some more than others. So how do you know which…Continue Reading

The DMT Tool Could Help You Chose an MS Treatment

DMT tool helps decisions

Sometimes it seems as if people with MS are asked to flip a coin to make what’s arguably the most important decision they make about their treatment: which disease-modifying therapy (DMT) to use. More than 20 DMTs are approved in the U.S. and many of those are available in the rest of the world. There are pills, injections, and infusions, and their efficacy, side effects, and costs vary significantly. One…Continue Reading

Zeposia Becomes Latest Weapon in the MS Battle

Zeposia fights MS

I have some new MS treatments to tell you about. The first is Zeposia (ozanimod) . By my unofficial count, it’s the 19th disease-modifying therapy to become available in the U.S. to treat multiple sclerosis. The Food and Drug Administration approved Zeposia in late March. Pharmaceutical companies usually rush to put their newly approved medications in doctors’ offices. But this time, with COVID-19 raging, Bristol-Myers Squibb wasn’t in a hurry.…Continue Reading

Hit MS Hard and Fast, Suggests New Study

Hit MS

How quickly to start a disease-modifying therapy after an MS diagnosis is a question that I frequently see when browsing online. It goes hand in hand with which DMT is best to start with. There are many things to consider when making that decision. Here’s a study that may help you weigh the benefits and risks hitting your MS hard and fast. Any DMT is better than none The study,…Continue Reading

Mindfulness: Attacking Your MS With Your Mind

Mindfulness

Can you use your mind to attack your MS, just as you use things such as medications and physical therapy? Some people who believe in the benefits of mindfulness think you can, at least to some extent. Mindfulness is defined as “the basic human ability to be fully present, aware of where we are and what we’re doing, and not overly reactive or overwhelmed by what’s going on around us,”…Continue Reading

Treating MS: Should Efficacy Trump Ease of Use?

MS treatment

There are more than a dozen disease-modifying therapies available for treating MS. Some are shots, some are infusions, and some are pills. Some are more effective than others. The marketing intelligence company Spherix Global Insights regularly surveys which of these treatments are being used by neurologists and what’s influencing their selection. Here’s what the latest Spherix quarterly survey shows about what’s being prescribed. Just over half of the 100 neurologists…Continue Reading

Is This a Key that Unlocks a Door for MS Stem Cell Treatments?

Stem cell therapy

Americans who want to treat their MS with a stem cell transplant have a tough road to follow. They’re forced to travel to Russia, Mexico, or somewhere else out of the country and to spend a lot of money to avoid the U.S. Food and Drug Administration’s stem cell treatment barrier. But now, a crack may be appearing in that wall. An article in STAT reports on surgeons at Houston’s Memorial…Continue Reading